Advances in Cancer Diagnostics Driving the Minimal Residual Disease Testing Market by 2035
The Minimal Residual Disease Testing Market is advancing rapidly as technological innovation transforms the way cancer is monitored and managed. MRD testing is designed to detect very small amounts of cancer that may remain in the body following treatment. Its growing role in evaluating treatment response and supporting personalized cancer care is making it an increasingly valuable component of...
0 Σχόλια 0 Μοιράστηκε 29 Views 0 Προεπισκόπηση
Comunidad EDUCA https://comunidadeduca.com